(28 days)
The Selectra CS lead introducer system is used to facilitate lead implantation in the left side of the heart via the coronary sinus.
The Selectra CS lead introducer system is a family of guiding catheters specifically used for the placement of coronary sinus leads. It is designed to assist with introducing leads into the left side of the heart via the coronary sinus. The system also facilitates access to the coronary sinus venous system as well as probing the coronary sinus.
This document is a 510(k) premarket notification for a medical device called the "Selectra CS Lead Introducer System 5F Guiding Catheters." This is a "Special 510(k)" submission, which typically means the device is a modification of a previously cleared device, and the modifications do not raise new questions of safety or effectiveness.
1. Table of Acceptance Criteria and Reported Device Performance
This document does not specify quantitative acceptance criteria or detailed device performance metrics in the way a traditional clinical study report might. Instead, it relies on the concept of "substantial equivalence" to a predicate device. The primary "acceptance criteria" for a Special 510(k) are that the proposed changes are limited to minor dimensional changes and that the usage, indications for use, contraindications, materials, and functions remain identical to the previously cleared predicate device.
| Acceptance Criteria (Implied for Special 510(k)) | Reported Device Performance (as stated in the document) |
|---|---|
| Changes limited to minor dimensional changes. | "The changes made to the Selectra 5F guiding catheters compared to the previously cleared Selectra 7F guiding catheters are limited to minor dimensional changes." |
| Usage remains unchanged. | "The usage of the Selectra 5F guiding catheters remains unchanged." |
| Product characteristics (indications for use, contraindications, materials, functions) are identical to the predicate device. | "and the product characteristics including the indications for use, contraindications, materials, and functions are identical to the previously cleared Selectra guiding catheters in submission K110461, cleared on April 20, 2011." |
2. Sample Size Used for the Test Set and Data Provenance
This document does not describe a clinical study with a "test set" in the traditional sense, as it is a Special 510(k) for a device with minor dimensional changes. Therefore, there is no mention of a sample size for a test set or data provenance (country of origin, retrospective/prospective). The submission relies on the existing clearance of the predicate device (K110461) and a demonstration that the new device is substantially equivalent and performs identically.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of those Experts
Not applicable. As explained above, there is no "test set" or ground truth established via expert review described in this submission. The device's safety and effectiveness are established through substantial equivalence to a predicate.
4. Adjudication Method for the Test Set
Not applicable. There is no test set or adjudication method described.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This document pertains to a guiding catheter, not an AI-powered diagnostic device, and therefore no MRMC study or AI assistance is mentioned.
6. If a Standalone (i.e. algorithm only without human-in-the loop performance) was done
Not applicable. This is not an algorithm or AI device.
7. The Type of Ground Truth Used
The "ground truth" for this Special 510(k) submission is the demonstration of substantial equivalence to the predicate device (Selectra 7F Guiding Catheters, K110461). This implies that the predicate device's safety and efficacy, established through its own clearance process, serve as the basis for the current device's acceptance, given the minor nature of the changes.
8. The Sample Size for the Training Set
Not applicable. This is not an AI/machine learning device; therefore, there is no training set mentioned.
9. How the Ground Truth for the Training Set was Established
Not applicable. As no training set is involved, there is no ground truth establishment for a training set.
{0}------------------------------------------------
April 22, 2011
BIOTRONIK, Selectra 5F Guiding Catheter, Special 510(k)
Selectra CS Lead Introducer System 5F Guiding Catheters Special 510(k) Premarket Notification
MAY 2 3 2011
1. 510(K) SUMMARY
Name and Address of Sponsor:
BIOTRONIK, Inc. 6024 Jean Road Lake Oswego, OR 97035
1028232 Establishment Registration Number:
Device Name:
Proprietary Name: Classification: Classification Name: Product Code:
Selectra Guiding Catheters Class II (21 CFR 870.1250) Percutaneous Catheter DQY, DRE
General Description:
The Selectra CS lead introducer system is a family of guiding catheters specifically used for the placement of coronary sinus leads. It is designed to assist with introducing leads into the left side of the heart via the coronary sinus. The system also facilitates access to the coronary sinus venous system as well as probing the coronary sinus. The following catheters are the subject of this Special 510(k):
- . Selectra IC 90-65 � Selectra IC 50-65
- Selectra IC 90-75 Selectra IC 50-75 . .
The Selectra 5F Guiding Catheters are packaged with the following components:
- 1 Selectra CS 5F guiding catheter (sterile) .
- . 1 technical manual or web-card (non-sterile)
Device Modification:
The changes made to the Selectra 5F guiding catheters compared to the previously cleared Selectra 7F guiding catheters are limited to minor dimensional changes.
The usage of the Selectra 5F guiding catheters remains unchanged and the product characteristics including the indications for use, contraindications, materials, and functions are identical to the previously cleared Selectra guiding catheters in submission K110461, cleared on April 20, 2011. Therefore, this previously cleared version will serve as the predicate device for the modified catheters included in this Special 510(k).
{1}------------------------------------------------
BIOTRONIK, Selectra 5F Guiding Catheter, Special 510(k). _____________________________________________________________________________________________________________________
Predicate Devices:
BIOTRONIK's Selectra (7F Guiding Catheters (K110461, 20-Apr-2011)
- Selectra Amplatz 6.0-45 .
- Selectra Amplatz 6.0-55 .
- Selectra Straight-45 .
- . Selectra Straight-55
- Selectra BIO2-45 .
- Selectra BIO2-55 .
- Selectra Extended Hook-45 .
- Selectra Extended Hook-55 .
- . Selectra Hook-45
Indication for Use:
The Selectra CS lead introducer system is used to facilitate lead implantation in the left side of the heart via the coronary sinus.
| Name and Address of Manufacturer: | BIOTRONIK SE & Co. KG (reg. no. 9610139)Woermannkehre 1,12359 Berlin, Germany011-49-30-689-05-1210 |
|---|---|
| Name and Address of Contract Manufacturer: | BIOTRONIK AG (reg. no. 8043892)Ackerstrasse 68180 Bülach,Switzerland 011-41-44-864-5169 |
| Name and Address of Contract Sterilizer: | Sterigenics Germany GmbH(reg. no. 3002807090)Kasteler Straße 45(Rheingaustrasse 190 - 196)D-65203 Wiesbaden, Germany |
| Contact Person(s) and Phone Number: | Jon BrumbaughVP, Regulatory Affairs and Compliance |
Phone (888) 345-0374 Fax (503) 635-9936 jon.brumbaugh@biotronik.com
- Selectra Hook-55 .
- Selectra MPEP-45 .
- Selectra MPEP-55 .
- Selectra MPH-45 .
- Selectra MPH-55 .
- Selectra Right-45 .
- Selectra Right-55 .
{2}------------------------------------------------
Indications for Use
510(k) Number (if known): TBD
Device Name: Selectra CS Lead Introducer System Indications for Use:
The Selectra CS lead introducer system is used to facilitate lead implantation in the left side of the heart via the coronary sinus.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(
Page 1 of 1
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized depiction of an eagle or bird-like figure with three curved lines forming its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the bird-like figure.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
MAY-2 3 2011
Biotronik, Inc. c/o Mr. Jon Brumbaugh Vice President, Regulatory Affairs and Compliance 6024 Jean Road Lake Oswego, OR 97035
Re: K111154
Selectra ic-50-65 Selectra ic-50-75 Selectra ic-90-65 Selectra ic-90-75 Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II Product Code: DQY, DRE Dated: April 22, 2011 Received: April 25, 2011
Dear Mr. Brumbaugh:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
{4}------------------------------------------------
Page 2 - Mr. Jon Brumbaugh
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH0ffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Bram D. Zuckerman, M.D.
Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
Indications for Use
510(k) Number (if known): TBD
Device Name: Selectra CS Lead Introducer System Indications for Use:
The Selectra CS lead introducer system is used to facilitiate lead implantation in the left via the coronary sinus.
Prescription Use V (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpa11 C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PACE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page 1 of 1
(Division Sign-Off)
Division of Cardiovascular Devices
510(k) Number K111154
§ 870.1250 Percutaneous catheter.
(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).